ࡱ> uwtq` R4bjbjqPqPd::#%  XXX844 J"&&&IIIIIII$MhP@J9 @J&&:J"""b@& &I"I""D0 SH& nX F$HLPJ0J7FBQ!BQHSHBQ SH<>Y,"$JJ2"^J   dt   t    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limited(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)APPOINTMENT OF DIRECTOR AND SUPERVISORThe Board announces that with effect from 25 June 2010, Mr. Xu Lie has been appointed as a non-executive director of the Company and Mr. Li Tianzhong has been appointed as a supervisor of the Company.The board of directors (the Board) of Shandong Xinhua Pharmaceutical Company Limited (the Company) announces that with effect from 25 June 2010, Mr. Xu Lie (Mr. Xu) has been appointed as a non-executive director of the Company and Mr. Li Tianzhong (Mr. Li) has been appointed as a supervisor of the Company.Mr. Xu lie, aged 44, is a senior economist and was a university graduate. He joined Shandong Xinhua Pharmaceutical Factory in 1986 and has been the deputy director and the director of the office, the deputy head of the office, and the manager of human resource department. Mr. Xu is currently the chairman of the labour union and the secretary to the disciplinary committee of the communist party of Shandong Xinhua Pharmaceutical Group Company Limited, and the chairman of the labour union and the secretary to the disciplinary committee of the communist party of the Company.Save as disclosed above, Mr. Xu :-did not hold any other directorship in any listed companies in the past three years or any positions with the Company or other members of the Group; has no relationship with any directors, senior management or substantial or controlling shareholders of the Company; anddoes not have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) at the date hereof.Mr. Xu has not entered into any service contract with the Company. The amount of his emoluments for 2010 is approximately RMB230,000. The emolument of Mr. Xu is determined by reference to his experience and the emoluments of other non-executive directors of the Company. The term of office of Mr. Xu will commence from 25 June 2010 to the expiry of the term of the sixth Board of the Company.Further, there is nothing in respect of Mr. Xu which needs to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Ltd (the Listing Rules) nor is there anything that needs to be brought to the attention of the shareholders of the Company.The Board takes this opportunity to welcome Mr. Xu to join the Board.Mr. Li Tianzhong, aged 47, is a senior engineer. He graduated from the Shandong Institute of Technology, specialising in industry automation. He joined Shandong Xinhua Pharmaceutical Factory in 1983. Mr. Li has been the engineer and director of the electricity workshop, manager of the trade department, supply and marketing department and drug department of the Company, assistant to the general manager, director and deputy general manager of Xinhua Lukang Pharmaceutical Group Corporation, director and deputy general manager and the chairman of the labour union of Shandong Xinhua Pharmaceutical Group Company Limited, director and the chairman of the labour union of the Company. Mr. Li is currently a director and deputy general manager of Shandong Xinhua Pharmaceutical Group Company Limited.Save as disclosed above, Mr. Li :-did not hold any other directorship in any listed companies in the past three years or any positions with the Company or other members of the Group; has no relationship with any directors, senior management or substantial or controlling shareholders of the Company; anddoes not have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) at the date hereof.Mr. Li has not entered into any service contract with the Company. The amount of his emoluments for 2010 is approximately RMB130,000. The emolument of Mr. Li is determined by reference to his experience and the emoluments of other supervisors of the Company. The term of office of Mr. Li will commence from 25 June 2010 to the expiry of the term of the sixth Supervisory Committee of the Company.Further, there is nothing in respect of Mr. Li which needs to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Listing Rules nor is there anything that needs to be brought to the attention of the shareholders of the Company.The Supervisory Committee takes this opportunity to welcome Mr. Li to join the Supervisory Committee of the Company. By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Guo Qin Chairman25 June 2010, Zibo, PRCAs at the date of this announcement, the Board comprises: Executive Directors:Ms. Guo Qin (Chairman)Mr. Ren FulongMr. Zhao Sq r s  x 0 2 V X IJhO='+hxcB*CJKHOJQJaJmH phsH #hxcB*KHOJQJmH ph# sH 1hxc6B*CJKHOJQJ]aJmH ph# sH @h:d6B*CJKHOJPJQJ]aJmH nHo(ph# sH tH1hxc6B*CJKHOJQJ]aJmH ph# sH  hxcKHhxc5PJ\o(#hxc5PJ\mH nHo(sH tH+jhxc5PJU\mHnHo(tHuhxcKHaJhxc6KH](jhxc6KHU]aJmHnHur t u v  x 2 X Z $$7$8$G$H$Ifa$ $7$8$H$a$ $3$a$ $7$8$H$a$N ؝1$3$N ؝1$3$G$ $7$8$G$H$a$444X Z     V )+3567;ADHʶʶʶʶʶʩsscMs+h^#hxcKHPJaJmH nHo(sH tHh^#hxcKHaJmH o(sH (h^#hxcKHPJaJmH nHsH tH"h^#hxc5KH\aJmH sH h^#hxcKHaJmH sH h^#hxcKHmH sH 'h^#hxcKHPJmH nHo(sH tHh^#hxcKHmH o(sH hxcKHOJQJmH sH hxc;PJnHo(tH hxc;o( hxco( !"ET $ & F7$8$H$a$ $7$8$H$a$ $7$8$G$H$a$[kd$$If5$$064 aHJ3Qab,-?AUX^a ıٟpcpppppph^#hxcKHmH sH +h^#hxcKHPJaJmH nHo(sH tH1h^#hxc5KHPJ\aJmH nHo(sH tH"h^#hxc5KH\aJmH sH $h^#hxcKHPJmH nHsH tH(h^#hxcKHPJaJmH nHsH tHh^#hxcKHaJmH sH .h^#hxc5KHPJ\aJmH nHsH tH& km.0DFNPTV\]jkluvSTvw89WYmpvy "ƭh^#hxcKHaJmH o(sH 1h^#hxc5KHPJ\aJmH nHo(sH tH(h^#hxcKHPJaJmH nHsH tH+h^#hxcKHPJaJmH nHo(sH tHh^#hxcKHaJmH sH >9:]l  "R[e}~$3$G$a$~!Z$6%3$G$ $3$G$a$ $7$8$G$H$a$ $ & F7$8$H$a$ $7$8$H$a$:<PRZ\`"*/0   "#Z[\egoq~۹m)h^#hxcB*OJPJaJnHphtHh^#hxcPJnHo(tHh^#hxc6h^#hxc\h^#hxc5\h^#hxc5 h^#hxch^#hxcKHmH sH (h^#hxcKHPJaJmH nHsH tH+h^#hxcKHPJaJmH nHo(sH tHh^#hxcKHaJmH sH *~4,4<4L4f4g4h444444Gkd$$If0!64 a $7$8$H$If$a$44444444444444444444444444444444ƾhxcCJo(h:d0JmHnHuhxc hxc0Jjhxc0JUh[jh[Uh^#hxcKHaJUh^#hxcKHPJnHo(tHh^#hxcKH%h^#hxcB*CJOJPJaJph#ongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. Sun MinggaoMr. Kwong Chi Kit, VictorNon-executive Directors: Mr. Liu Zhenwen Mr. Zhao BinMr. Xu LiePAGE PAGE 14444444444444444444&`#$ $7$8$H$a$Gkd$$If0!64 a444444444444444444444444 $7$8$H$a$8&P 1h2PP. A!"#$% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCBT[                ڤO        p@B        2ZJ        B:T                Fg3         8        Vj        @         Z)        `         R ,*mZ[xc:d;^#Z"#KT 0| !"HIJKLMNOPQRSTUVWXYZ[]^a 3U;S+0S+0S+0S+0S+0S+0S+0S+0S+0S+0@,E |L4vvu`@ @h@Unknown Gz Times New Roman5Symbol3& z Arial;[SOSimSunC .PMingLiUe0}fԚaTimes-ItalicTimes New Roman_ Times-RomanTimes New RomanKE  .DFKai-SBPMingLiU?5 .MingLiU0}fԚI Arial Unicode MSKPMCHM I+ Times[SO 1hƺff ' &' &!?!),.:;?]}    " % & ' 2 t%00 0 000000013468:<>@BDOPQRTUVWZ\^ \]d([{  5 0 0 00000579;=?ACY[][d2qHX?R 2~The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation Charltons_o(u7bH          Oh+'0(4HT`t    The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation Charltons Normal.dot ΢û6Microsoft Office Word@e@ȳ@s!/@'՜.+,0 X`t|  Charltons&    !"#$%&'()*+,-./012456789:<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcefghijkmnopqrsvRoot Entry FzwxData 31Table;QWordDocumentdSummaryInformation(dDocumentSummaryInformation8lCompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q